REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Metro Drug Inc (Philippines)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Metro Drug Inc Profile Updated: January 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Metro Drug Inc. is in the business of distribution of pharmaceutical and healthcare products in the Philippines. The company was incorporated in 1931 and is based in Taguig City.

Legal Address
Sta. Rosa Estate Barangay Macabiling Sta. Rosa, Laguna
Sta. Rosa; Region 4; Postal Code: 4026

Contact Details: Purchase the Metro Drug Inc report to view the information.

Basic Information
Total Employees:
Purchase the Metro Drug Inc report to view the information.
Outstanding Shares:
Purchase the Metro Drug Inc report to view the information.
Financial Auditors:
Purchase the Metro Drug Inc report to view the information.
Incorporation Date:
November 03, 1997
Key Executives
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Acting Corporate Secretary
Purchase this report to view the information.
Contact Person
Purchase this report to view the information.
Chairman/Pres./GM
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Metro Drug Inc report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
7.55%▲
Total operating revenue
7.8%▲
Operating profit (EBIT)
72.57%▲
Net Profit (Loss) for the Period
98.08%▲
Total assets
9.03%▲
Total equity
29.28%▲
Operating Profit Margin (ROS)
0.83%▲
Net Profit Margin
0.67%▲
Return on Equity (ROE)
11.33%▲
Debt to Equity Ratio
-101.27%▼
Quick Ratio
0.01%▲
Cash Ratio
-0.06%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo